These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2014883)

  • 21. HIV seroprevalence surveys in sexually transmitted disease clinics.
    Onorato IM; McCray E; Pappaioanou M; Johnson R; Aral S; Hardy AM; Dondero TJ
    Public Health Rep; 1990; 105(2):119-24. PubMed ID: 2108455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Family planning clinic services in the United States, 1994.
    Frost JJ
    Fam Plann Perspect; 1996; 28(3):92-100. PubMed ID: 8827144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence rates of human immunodeficiency virus infection at sentinel hospitals in the United States. The Sentinel Hospital Surveillance Group.
    St Louis ME; Rauch KJ; Petersen LR; Anderson JE; Schable CA; Dondero TJ
    N Engl J Med; 1990 Jul; 323(4):213-8. PubMed ID: 2366832
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in HIV seroprevalence among persons attending sexually transmitted disease clinics in the United States, 1988-1992.
    Weinstock HS; Sidhu J; Gwinn M; Karon J; Petersen LR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Aug; 9(5):514-22. PubMed ID: 7627627
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel surveillance and cross sectional survey on HIV infection prevalence: a comparative study.
    Kwesigabo G; Killewo JZ; Sandstrom A
    East Afr Med J; 1996 May; 73(5):298-302. PubMed ID: 8756031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increasing HIV-1 seroprevalence associated with genital ulcer disease, New York City, 1990-1992.
    Torian LV; Weisfuse IB; Makki HA; Benson DA; DiCamillo LM; Toribio FE
    AIDS; 1995 Feb; 9(2):177-81. PubMed ID: 7718189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low prevalence of human immunodeficiency virus type-1 (HIV-1) infection in population attending a major hospital in New Delhi, India.
    Aggarwal RK; Chattopadhya D; Kumari S
    J Commun Dis; 1996 Mar; 28(1):45-8. PubMed ID: 8778180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeted HIV screening at a Los Angeles prenatal/family planning health center.
    Fehrs LJ; Hill D; Kerndt PR; Rose TP; Henneman C
    Am J Public Health; 1991 May; 81(5):619-22. PubMed ID: 2014863
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV infection among non-injecting drug users entering drug treatment, United States, 1989-1992. Field Services Branch.
    Lehman JS; Allen DM; Green TA; Onorato IM
    AIDS; 1994 Oct; 8(10):1465-9. PubMed ID: 7818818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of HIV-2 infection in a family planning clinic in Lisbon.
    Victorino RM; Guerreiro D; Lourenço MH; Ferreira S; Teles LC
    Int J STD AIDS; 1992; 3(4):281-4. PubMed ID: 1504161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Continuity and change within an HIV epidemic. Injecting drug users in New York City, 1984 through 1992.
    Des Jarlais DC; Friedman SR; Sotheran JL; Wenston J; Marmor M; Yancovitz SR; Frank B; Beatrice S; Mildvan D
    JAMA; 1994 Jan; 271(2):121-7. PubMed ID: 8264066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimates of disease incidence in women based on antenatal or neonatal seroprevalence data: HIV in New York City.
    Ades AE; Medley GF
    Stat Med; 1994 Sep; 13(18):1881-94. PubMed ID: 7997720
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Family planning clinic services in the United States: patterns and trends in the late 1990s.
    Frost JJ; Ranjit N; Manzella K; Darroch JE; Audam S
    Fam Plann Perspect; 2001; 33(3):113-22. PubMed ID: 11407434
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Providing ART to HIV Seropositive Persons Who Use Drugs: Progress in New York City, Prospects for "Ending the Epidemic".
    Jarlais DC; Arasteh K; McKnight C; Feelemyer J; Hagan H; Cooper HL; Campbell AN; Tross S; Perlman DC
    AIDS Behav; 2016 Feb; 20(2):353-62. PubMed ID: 25731661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors for HIV-1 seroprevalence among family planning clients in Dar es Salaam, Tanzania.
    Kapiga SH; Lyamuya EF; Vuylsteke B; Spiegelman D; Larsen U; Hunter DJ
    Afr J Reprod Health; 2000 Apr; 4(1):88-99. PubMed ID: 11000712
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family planning service provision in rural areas: a survey in Washington State.
    Dobie SA; Gober L; Rosenblatt RA
    Fam Plann Perspect; 1998; 30(3):139-42, 147. PubMed ID: 9635263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV seroprevalence in newborns in New York State.
    Novick LF; Berns D; Stricof R; Stevens R; Pass K; Wethers J
    JAMA; 1989 Mar 24-31; 261(12):1745-50. PubMed ID: 2918672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A blinded survey of the seroprevalence of HIV-1 infection in an inner-city adolescent and young adult population attending a community hospital in the United States.
    Purswani MU; Hagmann S; Bakshi SS; Matias AR; Nubel CA; Neugebauer R; Dunne JM; Kairam R
    J Adolesc Health; 2007 Feb; 40(2):182-4. PubMed ID: 17259063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV seroprevalence in women of childbearing age in Benin City, Nigeria.
    Offor E; Okolo AA
    Afr J Reprod Health; 1997 Sep; 1(2):36-40. PubMed ID: 10214413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of human immunodeficiency virus infection in women in the United States.
    Shapiro CN; Schulz SL; Lee NC; Dondero TJ
    Obstet Gynecol; 1989 Nov; 74(5):800-8. PubMed ID: 2682415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.